MS Pharma Saudi was established in 2018 and currently operates two GMP-certified manufacturing sites in the Kingdom, approved by the Saudi Food and Drug Authority (SFDA)

The first facility is a full-scale manufacturing site for oral solids, with additional lines dedicated to secondary packaging across various dosage forms

The second is a newly launched, first-of-its-kind biologics facility in Saudi Arabia and the region. It is equipped to handle a wide range of formats such as liquid vials, freeze-dried vials, cartridges, and prefilled syringes or pens, and is capable of producing complex biologics like monoclonal antibodies and peptides in line with international regulatory standards

MS Pharma Saudi currently has approximately 78 INNs (162 SKUs) marketed locally, with an additional 42 INNs (60 SKUs) under registration